Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Assessment of i.p. injection of [18F]fallypride for behavioral neuroimaging in rats.

Yoder KK, Mock BH, Zheng QH, McCarthy BP, Riley AA, Hutchins GD.

J Neurosci Methods. 2011 Mar 15;196(1):70-5. doi: 10.1016/j.jneumeth.2010.12.027. Epub 2011 Jan 8.

PMID:
21219928
2.

Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.

Constantinescu CC, Coleman RA, Pan ML, Mukherjee J.

Synapse. 2011 Aug;65(8):778-87. doi: 10.1002/syn.20904. Epub 2011 Mar 21.

3.

Impact of isoflurane anesthesia on D2 receptor occupancy by [18F]fallypride measured by microPET with a modified Logan plot.

Tantawy MN, Peterson TE, Jones CK, Johnson K, Rook JM, Conn PJ, Baldwin RM, Ansari MS, Kessler RM.

Synapse. 2011 Nov;65(11):1173-80. doi: 10.1002/syn.20955. Epub 2011 Jun 17.

4.

Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.

Meyer PT, Salber D, Schiefer J, Cremer M, Schaefer WM, Kosinski CM, Langen KJ.

Nucl Med Biol. 2008 Jul;35(5):543-8. doi: 10.1016/j.nucmedbio.2008.03.006.

PMID:
18589298
5.

[(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.

Tantawy MN, Jones CK, Baldwin RM, Ansari MS, Conn PJ, Kessler RM, Peterson TE.

Nucl Med Biol. 2009 Nov;36(8):931-40. doi: 10.1016/j.nucmedbio.2009.06.007. Epub 2009 Oct 3.

6.
8.

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.

Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.

Nucl Med Biol. 1999 Jul;26(5):519-27.

PMID:
10473190
9.

Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.

Schiffer WK, Mirrione MM, Dewey SL.

J Nucl Med. 2007 Feb;48(2):277-87.

10.

Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.

Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.

Neuroimage. 2005 Feb 1;24(3):822-31. Epub 2004 Nov 24.

PMID:
15652317
11.

Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.

Honer M, Brühlmeier M, Missimer J, Schubiger AP, Ametamey SM.

J Nucl Med. 2004 Mar;45(3):464-70.

12.

Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals.

Patel VD, Lee DE, Alexoff DL, Dewey SL, Schiffer WK.

Neuroimage. 2008 Jul 1;41(3):1051-66. doi: 10.1016/j.neuroimage.2008.02.065. Epub 2008 Mar 19.

PMID:
18442926
13.

Imaging of alcohol-induced dopamine release in rats:preliminary findings with [(11) C]raclopride PET.

Sullivan JM, Risacher SL, Normandin MD, Yoder KK, Froehlich JC, Morris ED.

Synapse. 2011 Sep;65(9):929-37. doi: 10.1002/syn.20921. Epub 2011 Mar 28.

14.

Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.

Millet P, Moulin-Sallanon M, Tournier BB, Dumas N, Charnay Y, Ibáñez V, Ginovart N.

Neuroimage. 2012 Sep;62(3):1455-68. doi: 10.1016/j.neuroimage.2012.05.075. Epub 2012 Jun 1.

PMID:
22659483
15.

Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.

Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M.

Synapse. 2008 Jun;62(6):399-408. doi: 10.1002/syn.20506.

PMID:
18361438
16.

Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIV.

Lee DE, Reid WC, Ibrahim WG, Peterson KL, Lentz MR, Maric D, Choyke PL, Jagoda EM, Hammoud DA.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00031.

17.

In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

Slifstein M, Hwang DR, Huang Y, Guo N, Sudo Y, Narendran R, Talbot P, Laruelle M.

Psychopharmacology (Berl). 2004 Sep;175(3):274-86.

PMID:
15024551
18.
19.

[123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.

Huang YR, Shih JM, Chang KW, Huang C, Wu YL, Chen CC.

Nucl Med Biol. 2012 Aug;39(6):826-32. doi: 10.1016/j.nucmedbio.2012.01.005. Epub 2012 Mar 29.

PMID:
22464847
20.

Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.

Rominger A, Wagner E, Mille E, Böning G, Esmaeilzadeh M, Wängler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P.

Synapse. 2010 Apr;64(4):313-22. doi: 10.1002/syn.20730.

PMID:
19957365

Supplemental Content

Support Center